The Latest Breaking News from Covid-19

Here's a roundup of top developments in the biotech space over the last 24 hours:

Unvaccinated travellers will still be required to meet one regulation

Prevalence of the virus continues to decline in all four nations.

The Centers for Disease Control and Prevention recommended that children ages 5 to 11 receive the newly authorized COVID-19 booster shot from Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX). Following the recommendation, many of the nation's doctors, pharmacies, and other vaccination sites are expected to begin offering the extra doses to the 28 million U.S. children…

While we might not be hearing the daily COVID numbers anymore, the virus hasn’t gone away. In the UK alone, thousands of new cases continue to be recorded every day.

Attempts to boost flagging GDP growth hindered by Covid lockdowns, Ukraine war and Sino-US tensions

RLX Technology Inc (NYSE:RLX) reported a first-quarter FY22 sales decline of 28.5% year-on-year to $270.4 million. The revenue decrease is primarily due to the impact of COVID-19 on the production plant in Shenzhen, which adversely affected production and shipment volume. The gross margin for the quarter contracted 770 basis points to 38.3%, and…

USA, Indonesia and the Philippines are some of the countries which have strict entry requirements including pre-departure coronavirus tests

The rules could be relaxed 'within days' for unvaccinated travellers from non-EU destinations.